Enhanced sensitivity of Beckman Coulter DxI 9000 reduces sample & reagent use

11 Nov 2024

The Beckman Coulter DxI 9000 analyzer features advanced technology like the Lumi-Phos PRO substrate, an upgraded luminometer, and precise low-volume pipetting, which enhances assay sensitivity. These improvements enable reduced sample and reagent volumes, conserving patient samples, minimizing packaging waste, and increasing tests per reagent pack. Studies on Access TSH, βhCG, and PSA assays show analytical performance is maintained with decreased volumes. This supports efficient, resource-conserving immunoassay development while maintaining performance standards.

This resource is shared as part of the global CLINICAL24 conversation. Visit the Innovation Hub to learn more about high-sensitivity immunoassay advances.

Links

Tags